Waratah Capital Advisors Ltd. Grows Stock Holdings in Chemed Co. (NYSE:CHE)

Waratah Capital Advisors Ltd. raised its position in shares of Chemed Co. (NYSE:CHEGet Rating) by 125.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,400 shares of the company’s stock after buying an additional 4,115 shares during the period. Waratah Capital Advisors Ltd.’s holdings in Chemed were worth $3,748,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. National Bank of Canada FI acquired a new stake in shares of Chemed in the fourth quarter valued at $40,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Chemed in the fourth quarter valued at $1,398,000. State of New Jersey Common Pension Fund D raised its stake in shares of Chemed by 5.6% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 8,676 shares of the company’s stock valued at $4,590,000 after acquiring an additional 457 shares in the last quarter. CWM LLC acquired a new stake in shares of Chemed in the fourth quarter valued at $147,000. Finally, Qube Research & Technologies Ltd acquired a new stake in shares of Chemed in the fourth quarter valued at $701,000. 90.01% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Chemed

In related news, Director Patrick P. Grace sold 262 shares of the firm’s stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $465.47, for a total transaction of $121,953.14. Following the transaction, the director now owns 3,270 shares of the company’s stock, valued at $1,522,086.90. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Patrick P. Grace sold 262 shares of the firm’s stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $465.47, for a total transaction of $121,953.14. Following the transaction, the director now owns 3,270 shares of the company’s stock, valued at $1,522,086.90. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, May 10th. The stock was sold at an average price of $502.00, for a total value of $1,004,000.00. Following the transaction, the chief executive officer now directly owns 128,185 shares in the company, valued at approximately $64,348,870. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 3,694 shares of company stock worth $1,842,096. Corporate insiders own 4.03% of the company’s stock.

Analysts Set New Price Targets

Separately, Royal Bank of Canada cut their price target on Chemed from $592.00 to $541.00 and set an “outperform” rating on the stock in a research note on Monday, August 1st.

Chemed Stock Up 1.2 %

Chemed stock traded up $5.84 during midday trading on Friday, reaching $478.25. The company’s stock had a trading volume of 40,542 shares, compared to its average volume of 67,587. Chemed Co. has a fifty-two week low of $403.00 and a fifty-two week high of $539.87. The company has a quick ratio of 0.68, a current ratio of 0.71 and a debt-to-equity ratio of 0.16. The company has a market cap of $7.13 billion, a P/E ratio of 26.60, a P/E/G ratio of 3.21 and a beta of 0.51. The business has a 50-day simple moving average of $480.51 and a 200-day simple moving average of $483.92.

Chemed (NYSE:CHEGet Rating) last posted its earnings results on Wednesday, July 27th. The company reported $4.84 EPS for the quarter, topping analysts’ consensus estimates of $4.78 by $0.06. Chemed had a return on equity of 44.64% and a net margin of 12.95%. The business had revenue of $531.29 million for the quarter, compared to analysts’ expectations of $538.07 million. During the same quarter in the previous year, the firm earned $4.60 earnings per share. The business’s revenue was down .2% compared to the same quarter last year. On average, research analysts expect that Chemed Co. will post 18.87 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 15th. Stockholders of record on Thursday, May 26th were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date was Wednesday, May 25th. Chemed’s dividend payout ratio (DPR) is currently 8.01%.

About Chemed

(Get Rating)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEGet Rating).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.